###begin article-title 0
Role of Apolipoprotein E in Anxiety
###end article-title 0
###begin p 1
Recommended by Patrice Venault
###end p 1
###begin p 2
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin p 3
###xml 54 62 <span type="species:ncbi:9606">patients</span>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
###xml 384 389 <span type="species:ncbi:9606">human</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 484 492 <span type="species:ncbi:9606">patients</span>
###xml 516 520 <span type="species:ncbi:10090">mice</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
###xml 550 554 <span type="species:ncbi:10090">mice</span>
###xml 686 690 <span type="species:ncbi:10090">mice</span>
###xml 714 718 <span type="species:ncbi:10090">mice</span>
Anxiety is most common among Alzheimer's disease (AD) patients with an age at onset under age 65. Apolipoprotein E4 (apoE4) is a risk factor for developing AD at an earlier age and might contribute to this effect. In mice, apoE plays a role in the regulation of anxiety, which might involve histamine receptor-mediated signaling and steroidogenesis in the adrenal gland. In addition, human apoE isoforms have differential effects on anxiety in adult mice lacking apoE and probable AD patients. Compared to wild-type mice, mice lacking apoE and apoE4 mice showed pathological alterations in the central nucleus of the amygdala, which is involved in regulation of anxiety. ApoE4, but not mice lacking apoE, or apoE3 mice showed impaired dexamethasone suppression of plasma corticosterone. Understanding how apoE modulates measures of anxiety might help the developments of therapeutic targets to reduce or even prevent measures of anxiety in health and in dementing illnesses.
###end p 3
###begin title 4
1. INTRODUCTION
###end title 4
###begin p 5
###xml 133 134 133 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 135 136 135 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 265 266 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 268 269 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 520 521 520 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 647 648 647 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 688 689 688 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 699 700 699 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 1041 1043 1041 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1124 1126 1124 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1255 1256 1255 1256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1258 1259 1258 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 82 90 <span type="species:ncbi:9606">patients</span>
###xml 221 229 <span type="species:ncbi:9606">patients</span>
###xml 708 716 <span type="species:ncbi:9606">patients</span>
###xml 848 856 <span type="species:ncbi:9606">patients</span>
###xml 890 897 <span type="species:ncbi:9606">patient</span>
###xml 941 948 <span type="species:ncbi:9606">patient</span>
###xml 961 968 <span type="species:ncbi:9606">patient</span>
###xml 1031 1039 <span type="species:ncbi:9606">patients</span>
###xml 1057 1064 <span type="species:ncbi:9606">patient</span>
###xml 1104 1111 <span type="species:ncbi:9606">patient</span>
Noncognitive behavioral changes are the major cause of institutionalization of AD patients and a major concern for their caregivers [1-3]. Such changes are also a negative predictor of survival and quality of life for AD patients and contribute to increased costs [4, 5]. However, they have received much less attention than cognitive impairments. Most pharmacological strategies for controlling behavioral changes, including treatment with benzodiazepines, cause deterioration in mental performance and motor function [6]. In AD, anxiety is inversely related to mini-mental state examination (MMSE) score (i.e., worse with more severe dementia) [7]. Anxiety symptoms occur in about 50% [8] to 75% [9] of AD patients. A study describing the relationship between anxiety and nighttime behavioral disturbance in a community dwelling sample of 153 AD patients revealed symptoms of anxiety and patient awakening associated with higher levels of patient anxiety and patient impairments in activities of daily living (ADL) in 56% of the patients [10]. Individual-patient anxiety symptoms were risk factors for patient awakenings [10]. Anxiety symptoms become more common as the disease progresses and are associated with greater disability in daily activities [7, 8]. In more than half of the cases, the caregivers demand therapeutic intervention regardless of the effects on cognitive and motor function. Therefore, there is a need to better understand the mechanisms underlying increased anxiety and to develop better treatments for these conditions.
###end p 5
###begin title 6
2. APOE, BRAIN FUNCTION, AND AD
###end title 6
###begin p 7
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 173 180 173 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 183 190 177 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 197 204 185 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 222 229 204 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 235 242 211 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 245 252 215 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 320 322 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 516 517 480 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 580 582 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 120 125 <span type="species:ncbi:9606">human</span>
###xml 463 471 <span type="species:ncbi:9606">patients</span>
ApoE plays an important role in the metabolism and redistribution of lipoproteins and cholesterol [11]. The three major human apoE isoforms are encoded by distinct alleles (epsilon2, epsilon3, and epsilon4). Compared with epsilon2 and epsilon3, epsilon4 increases the risk of cognitive impairments and of developing AD [12]. This increased risk might involve a loss of trophic function of apoE4 or gain of toxic function of apoE4. Anxiety is most common among AD patients with a younger age at onset (under age 65) [7]. ApoE4 is a risk factor for developing AD at an earlier age [12] and might contribute to this effect.
###end p 7
###begin title 8
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 66 69 66 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
3. ROLE OF APOE IN REGULATING MEASURES OF ANXIETY REVEALED IN APOE-/- MICE
###end title 8
###begin p 9
###xml 74 82 74 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 489 493 489 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 493 496 493 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 511 517 511 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Unc</sup>
###xml 687 691 687 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 691 694 691 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 728 732 728 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 732 735 732 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 779 781 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 248 252 <span type="species:ncbi:10090">Mice</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
###xml 542 546 <span type="species:ncbi:10090">mice</span>
###xml 722 726 <span type="species:ncbi:10090">mice</span>
###xml 736 740 <span type="species:ncbi:10090">mice</span>
###xml 844 848 <span type="species:ncbi:10090">mice</span>
The elevated plus maze can be used to assess measures of anxiety in mice (Figure 1). The plus maze consists of a perpendicular cross elevated above the floor. The sides of one axis are walled off. There are infrared photobeams to record movements. Mice will prefer the safety of the enclosed, darker arms, but they like to explore the open arms and poke over the edge. Less anxious mice will venture more onto the open arms, and poke their heads more over the edges of the open arms. Male Apoe-/- (C57BL/6J-Apoetm1Unc) and wild-type C57BL/6J mice were obtained from the Jackson Laboratory (Bar Harbor, Me). When measures of anxiety in the elevated plus maze were assessed in 6-month-old Apoe-/- male and wild-type control mice, Apoe-/- mice showed increased measures of anxiety [13]. These changes are age-dependent and not seen in 3-month-old mice.
###end p 9
###begin title 10
4. APOE AND ADRENAL STEROIDOGENESIS
###end title 10
###begin p 11
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 424 428 424 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 428 431 428 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 632 636 632 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 636 639 636 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 771 775 771 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 775 778 775 778 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 972 974 972 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 977 981 977 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 981 984 981 984 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1059 1061 1059 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
###xml 640 644 <span type="species:ncbi:10090">mice</span>
###xml 779 783 <span type="species:ncbi:10090">mice</span>
###xml 985 989 <span type="species:ncbi:10090">mice</span>
Liver and brain are the major sites of apoE synthesis. However, many other tissues, particularly steroidogenic tissues such as the adrenal gland, also express apoE [14, 15]. Adrenal apoE expression is the highest in cortical cells that synthesize glucocorticoids (GCs), declines when steroidogenesis is stimulated, and increases when it is blocked [14, 15]. The function of apoE synthesized by the adrenal gland is unclear. Apoe-/- mice show an age-dependent dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis. The HPA axis regulates the secretion of GCs through a mechanism that primarily affects the adrenal gland. In Apoe-/- mice, activation of the HPA axis is seen at the same time as increased measures of anxiety are observed in the elevated plus maze. Apoe-/- mice have an age-dependent increase in basal adrenal corticosterone content and abnormally increased plasma corticosterone after restraint stress and anxiety testing in the elevated plus maze [13]. Apoe-/- mice also show increases in lipid droplets in adrenal cortex and medulla [13]. These data are consistent with hypersecretion of adrenal corticosterone and increased adrenal corticosterone content and with the reported inverse relationship between the levels of apoE mRNA and adrenal steroidogenesis, and they suggest a key role for apoE in the tonic inhibition of steroidogenesis and adrenal cortical activity.
###end p 11
###begin title 12
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 32 35 32 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
5. HISTAMINE AND ANXIETY OF APOE-/- MICE
###end title 12
###begin p 13
###xml 41 43 41 43 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 137 141 137 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 141 144 141 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 271 275 271 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 275 278 275 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 554 555 554 555 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 672 676 672 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 676 683 676 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;mice</sup>
###xml 814 815 814 815 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 973 974 973 974 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1096 1098 1096 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1397 1401 1397 1401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 1401 1404 1401 1404 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
###xml 476 482 <span type="species:ncbi:9606">person</span>
###xml 495 499 <span type="species:ncbi:10090">mice</span>
###xml 679 683 <span type="species:ncbi:10090">mice</span>
###xml 954 958 <span type="species:ncbi:10090">mice</span>
###xml 1070 1074 <span type="species:ncbi:10090">mice</span>
###xml 1204 1208 <span type="species:ncbi:10090">mice</span>
###xml 1405 1409 <span type="species:ncbi:10090">mice</span>
Histamine increases measures of anxiety [16], and altered histamine signaling could contribute to increased measures of anxiety in adult Apoe-/- male mice. We began to assess the possible role of histamine receptor-mediated signaling in regulating measures of anxiety in Apoe-/- and wild-type mice. Drugs were dissolved in saline and administered by intraperitoneal injection 1 hour before behavioral testing at the indicated doses, selected based on preliminary studies. The person testing the mice was blinded to genotype and treatment. The histamine H3 receptors modulate histamine release and synthesis via negative feedback. We assessed whether young (3-5-month old) Apoe-/-mice, which show similar measures of anxiety in the anxiety-provoking open arms of the plus maze, respond differentially to histamine H3 receptor ligands. Anxiety levels were assessed 1 hour after intraperitoneal administration of thioperamide (5 mg/kg) or saline. Wild-type mice treated with H3 receptor antagonist thioperamide showed increased measures of anxiety as compared to wild-type mice treated with saline [17]. The total activity in the closed arms was comparable in the saline- and thioperamide-treated wild-type mice. These data indicate that the differences in measures in the open arms were not caused by differences in activity levels. In contrast, thioperamide had no effect on measures of anxiety in Apoe-/- mice.
###end p 13
###begin p 14
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 48 51 48 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 59 60 59 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 726 730 726 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 730 733 730 733 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 851 853 851 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 877 878 877 878 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 889 891 889 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 928 929 928 929 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 994 995 994 995 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1067 1071 1067 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 1071 1074 1071 1074 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1102 1103 1102 1103 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1152 1153 1152 1153 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1180 1182 1180 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1345 1349 1345 1349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 1349 1352 1349 1352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1450 1454 1448 1452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 1454 1457 1452 1455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1542 1546 1536 1540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 1546 1549 1540 1543 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1640 1644 1632 1636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 1644 1647 1636 1639 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1826 1827 1818 1819 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1850 1851 1842 1843 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 512 516 <span type="species:ncbi:10090">mice</span>
###xml 734 738 <span type="species:ncbi:10090">mice</span>
###xml 1075 1079 <span type="species:ncbi:10090">mice</span>
###xml 1224 1228 <span type="species:ncbi:10090">mice</span>
###xml 1353 1357 <span type="species:ncbi:10090">mice</span>
###xml 1648 1652 <span type="species:ncbi:10090">mice</span>
Next we determined whether in wild-type and Apoe-/- mice, H3 antagonists also have differential effects on novel object recognition [18, 19]. During the training session, mice were allowed to explore for 15 minutes an open field containing two objects. For the retention session (24 hours later), they were placed back into the same open field for 15 minutes, after one of the familiar objects had been replaced with a novel object and the other familiar object with an exact replica. The percentage of time the mice spent exploring the novel versus the familiar object relative to the total amount of time they explored either object in the retention session was used as a measure of object recognition memory. Wild-type and Apoe-/- mice received saline, thioperamide (5 mg/kg), or clobenpropit (10 mg/kg) during the training and retention sessions [17]. The recently cloned H4 receptor [20] was found to have an affinity for H3-specific ligands. To rule out the possible contribution of the H4 receptor to the effects of thioperamide, we also treated wild-type and Apoe-/- mice with clobenpropit, a H3-specific antagonist that was reported to be an H4 receptor agonist as well [20]. In the training session, all groups of mice spent a comparable amount of time exploring each object. In the retention session, the saline-treated wild-type and Apoe-/- mice spent significantly more time exploring the novel object (wild-type: 8.37 +/- 0.93 seconds; Apoe-/-: 9.34 +/- 2.76 seconds) than the familiar object (wild-type: 5.43 +/- 0.69 seconds; Apoe-/-: 5.15 +/- 1.25 seconds), whereas the thioperamide- and clobenpropit-treated wild-type and Apoe-/- mice spent equal amounts of time exploring both objects. The similar effects of thioperamide and clobenpropit on novel object recognition indicate that they are mediated by the H3 receptor and not the H4 receptor.
###end p 14
###begin p 15
###xml 22 23 22 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 108 112 108 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 112 115 112 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 633 637 633 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 637 640 637 640 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 858 862 858 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 862 865 862 865 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 962 966 962 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 966 969 966 969 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 991 992 991 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 159 163 <span type="species:ncbi:10090">Mice</span>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 641 645 <span type="species:ncbi:10090">mice</span>
###xml 866 870 <span type="species:ncbi:10090">mice</span>
###xml 985 989 <span type="species:ncbi:10090">mice</span>
To determine whether H3 ligands have differential effects on emotional learning and memory in wild-type and Apoe-/- mice, passive avoidance learning was used. Mice were placed in a lighted compartment of a chamber also containing a dark compartment. They entered the dark compartment by preference where they received a brief and slight foot shock (0.3 mA for 1 second). After 24 hours, the mice were again placed in the light compartment, and the time to reenter the dark compartment was measured. Drugs were administered 1 hour before behavioral testing on both days. Both saline- and thioperamide- (5 mg/kg) treated wild-type and Apoe-/- mice showed emotional learning and memory as the time to reenter the dark chamber was significantly higher on day 2 than day 1. There was no effect of thioperamide but consistent with increased measures of anxiety of Apoe-/- mice in the elevated plus maze, the latency to enter the dark compartment on day 1 was lower in Apoe-/- than wild-type mice (P < .05, Tukey-Kramer).
###end p 15
###begin p 16
###xml 47 48 47 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 82 85 82 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 185 186 185 186 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 262 263 262 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 267 272 267 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 364 366 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 401 404 397 400 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 454 458 448 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 458 461 452 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 512 516 502 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 516 519 506 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 580 584 566 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 584 587 570 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 616 620 600 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 620 623 604 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 670 673 654 657 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 766 767 750 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 852 853 836 837 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 955 956 939 940 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1038 1040 1022 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 642 646 <span type="species:ncbi:10090">mice</span>
To determine whether there are differences in H3 receptor expression in young Apoe-/- and wild-type mice (3-5-month old) which could have contributed to their differential response to H3 antagonists on measures of anxiety, we performed saturation analysis with [3H]-Nalpha-methylhistamine (NAMH) in brain regions that have been implicated in cognition or emotion [17]. The total number of receptors (Bmax in nM) in the amygdala (wild-type: 87.3 +/- 2.5; Apoe-/-: 81.8 +/- 2.3), cortex (wild-type: 119.9 +/- 3.0; Apoe-/-: 56.8 +/- 5.8), and hippocampus (wild-type: 108.4 +/- 10.5; Apoe-/-: 29.1 +/- 1.7) was lower in Apoe-/- than in wild-type mice. In the hypothalamus, Bmax was not different between the groups. There was no difference in the binding affinities of [3H]-NAMH in any brain region. Thus, there is no simple association between levels of H3 receptor expression in structures associated with anxiety versus cognition, which could explain why H3 antagonists impaired hippocampus- and cortex-dependent novel object recognition [18] but did not increase more amygdala-dependent measures of anxiety in the plus maze.
###end p 16
###begin p 17
###xml 52 53 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 51 53 51 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1<sup>&#8722;</sup></sub>
###xml 68 69 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 67 69 67 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2<sup>&#8722;</sup></sub>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 128 132 128 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 132 135 132 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 173 174 173 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 236 237 236 237 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 243 244 243 244 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 280 284 280 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 284 287 284 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 410 414 410 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 414 417 414 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 515 516 515 516 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 557 558 557 558 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 605 609 605 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 609 612 609 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 719 723 719 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 723 726 723 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 753 755 753 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 901 905 901 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 905 908 905 908 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1133 1134 1133 1134 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1245 1246 1245 1246 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1336 1337 1336 1337 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1404 1406 1404 1406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1444 1448 1444 1448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 1448 1451 1448 1451 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1464 1465 1464 1465 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1608 1610 1608 1610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1612 1614 1612 1614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1651 1652 1651 1652 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1675 1676 1675 1676 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1710 1712 1710 1712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
###xml 418 422 <span type="species:ncbi:10090">mice</span>
###xml 613 617 <span type="species:ncbi:10090">mice</span>
###xml 727 731 <span type="species:ncbi:10090">mice</span>
###xml 909 913 <span type="species:ncbi:10090">mice</span>
###xml 1101 1105 <span type="species:ncbi:10090">mice</span>
###xml 1198 1202 <span type="species:ncbi:10090">mice</span>
###xml 1305 1309 <span type="species:ncbi:10090">mice</span>
###xml 1452 1456 <span type="species:ncbi:10090">mice</span>
In experimental models of anxiety, stimulation of H1-, but not of H2-, receptors increases measures of anxiety [16, 21, 22]. In Apoe-/- mice, reduced negative feedback via H3 receptors could increase histamine release and signaling of H1 and H2 receptors. To determine whether in Apoe-/- mice increased signaling of these receptors contributed to the increased measures of anxiety, 3-5-month-old wild-type and Apoe-/- mice were assessed in the elevated plus maze 1 hour after intraperitoneal administration of the H1 antagonist mepyramine (5.6 mg/kg), the H2 antagonist zolantidine (10 mg/kg), or saline. Apoe-/- mice treated with mepyramine, but not with zolantidine, showed reduced measures of anxiety as compared to Apoe-/- mice treated with saline [17]. The total activity in the closed arms was comparable and not significantly different between the saline-, mepyramine-, and zolantidine-treated Apoe-/- mice, indicating that the differences in measures in the open arms were not caused by differences in activity levels. In contrast, mepyramine had no effect on measures of anxiety in wild-type mice. The lack of an effect of H1 receptor blockade on measures of anxiety in wild-type C57Bl/6J mice is consistent with the lack of effect of H1 receptor blockade on measures of anxiety in wild-type ddY mice and it supports that the H1 receptor becomes activated at higher levels of histamine release [21]. The reduced measures of anxiety in Apoe-/- mice after H1 receptor blockade are consistent with the reported antagonizing effects of mepyramine on experimental anxiety induced by histamine releasers [16, 21] and the anxiogenic effects of the H1 receptor agonist and H3 receptor antagonist betahistine [22].
###end p 17
###begin p 18
###xml 3 7 3 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 7 10 7 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 349 350 347 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 385 386 381 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 392 393 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 426 430 422 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 430 433 426 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 461 462 455 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 498 499 490 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 545 546 537 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 594 595 586 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 694 695 684 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 729 730 717 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 736 737 724 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 770 774 758 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 774 777 762 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 808 809 794 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 844 845 828 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 876 880 860 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 880 883 864 867 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1010 1011 994 995 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1071 1075 1055 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 1075 1078 1059 1062 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1131 1132 1115 1116 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1194 1198 1178 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 1198 1201 1182 1185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
###xml 505 509 <span type="species:ncbi:10090">mice</span>
###xml 662 666 <span type="species:ncbi:10090">mice</span>
###xml 778 782 <span type="species:ncbi:10090">mice</span>
###xml 884 888 <span type="species:ncbi:10090">mice</span>
###xml 1093 1097 <span type="species:ncbi:10090">mice</span>
###xml 1222 1226 <span type="species:ncbi:10090">mice</span>
In Apoe-/- mice, the effects of mepyramine on measures of anxiety in the plus maze were not associated with a reduced HPA axis response. Plasma ACTH and corticosterone levels were assessed directly after plus-maze testing [23]. Compared to saline controls, mepyramine reduced the plasma corticosterone levels in wild-type (saline: 179 +/- 38 ng/mL, n = 6; mepyramine: 89 +/- 26 ng/mL, n = 6; P < .05 Tukey-Kramer), but not in Apoe-/- (saline: 206 +/- 30 ng/mL, n = 8; mepyramine: 224 +/- 10 ng/mL, n = 9) mice. There were an effect of genotype (P < .01) and a genotype x treatment interaction (P = .0474). Mepyramine also reduced plasma ACTH levels in wild-type mice (saline: 121 +/- 20 pg/mL, n = 6; mepyramine: 77 +/- 9 pg/mL, n = 6; P < .05 Tukey-Kramer), but not in Apoe-/- mice (saline: 57 +/- 5 pg/mL, n = 8; mepyramine: 62 +/- 11 pg/mL, n = 9). These data show that in Apoe-/- mice, mepyramine does not reduce measures of anxiety by inhibiting the HPA axis response. The dissociation of the effects of H1 receptor blockade on anxiety from those on the HPA axis in Apoe-/- and wild-type mice and the differential effects of H3 receptor blockade on novel object recognition and anxiety in Apoe-/-, but not wild-type, mice suggest that differential pharmacokinetic profiles of histaminergic drugs in the two genotypes do not underlie the behavioral results.
###end p 18
###begin p 19
###xml 29 30 29 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 80 83 80 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 130 131 130 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 245 248 245 248 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 301 305 299 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 305 308 303 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 364 368 358 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 368 371 362 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 432 436 422 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 436 439 426 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 505 509 491 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 509 512 495 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 534 538 518 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 538 541 522 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 596 597 580 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 556 560 <span type="species:ncbi:10090">mice</span>
There are no differences in H1 receptor expression in young (3-5-month old) Apoe-/- and wild-type mice. Saturation analysis with [3H] mepyramine in brain regions implicated in cognition or emotion [17] showed similar total number of receptors (Bmax in nM) in the amygdala (wild-type: 103.4 +/- 13.16; Apoe-/-: 120.9 +/- 20.92), cortex (wild-type: 126.5 +/- 8.472; Apoe-/-: 170.0 +/- 13.02), hippocampus (wild-type: 104.0 +/- 10.13; Apoe-/-: 98.66 +/- 11.03), and hypothalamus (wild-type: 218.7 +/- 22.33; Apoe-/-: 159.4 +/- 29.00) of Apoe-/- and wild-type mice and similar binding affinities of [3H]-mepyramine in each brain region.
###end p 19
###begin title 20
6. HUMAN APOE ISOFORMS AND MEASURES OF ANXIETY
###end title 20
###begin p 21
###xml 119 123 119 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 123 126 123 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 183 187 183 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 187 190 187 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 367 374 367 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 21 26 <span type="species:ncbi:9606">human</span>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 143 148 <span type="species:ncbi:9606">human</span>
###xml 196 200 <span type="species:ncbi:10090">mice</span>
###xml 209 214 <span type="species:ncbi:9606">human</span>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
###xml 329 333 <span type="species:ncbi:10090">mice</span>
###xml 494 498 <span type="species:ncbi:10090">mice</span>
We hypothesized that human apoE isoforms have differential effects on measures of anxiety in adult (6-8 months of age) Apoe-/- mice expressing human apoE3 or apoE4 at similar levels. Apoe-/- male mice without human apoE expression and apoE4 mice showed increased measures of anxiety in the elevated plus maze, whereas apoE3 male mice behaved like wild-type controls (Table 1). These differential effects of apoE isoforms on anxiety were age-dependent and not seen in young (2-4-month-old) male mice.
###end p 21
###begin p 22
###xml 367 371 367 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 371 374 371 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 381 388 381 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 550 552 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
###xml 457 462 <span type="species:ncbi:10090">mouse</span>
The isoform-specific effects of apoE are independent of the cellular source of apoE. When anxiety levels in the elevated plus maze were assessed in a cohort of 6-month-old GFAP-apoE male mice, in which the expression of apoE3 or apoE4 is targeted to astrocytes, GFAP-apoE3, but not GFAP-apoE4, male mice showed less measures of anxiety in the elevated plus maze than Apoe-/- mice (Table 2). Similar results were seen in the elevated zero maze, in which the mouse does not need to turn around in the open areas in order to return to the closed areas [24].
###end p 22
###begin p 23
###xml 376 384 376 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 591 595 591 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 595 598 595 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 857 861 857 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 861 864 861 864 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 890 892 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 599 603 <span type="species:ncbi:10090">mice</span>
###xml 673 677 <span type="species:ncbi:10090">mice</span>
###xml 709 713 <span type="species:ncbi:10090">mice</span>
###xml 758 762 <span type="species:ncbi:10090">mice</span>
###xml 840 844 <span type="species:ncbi:10090">mice</span>
###xml 884 888 <span type="species:ncbi:10090">mice</span>
The elevated plus maze is different from tests that involve unavoidable anxiety-provoking stimuli, such as acoustic stimuli. By assessing the acoustic startle response, we determined that apoE also has age- and isoform-specific effects on anxiety elicited by unavoidable acoustic stimuli. To measure startle reflex, we used the SM100 startle monitor system (Hamilton-Kinder) (Figure 3). At 3 months of age, there were no effects of apoE isoforms on the acoustic startle response. However, there were differential effects of apoE isoforms on the acoustic startle response at 6 months of age. Apoe-/- mice showed a higher acoustic startle response than age-matched wild-type mice. This was not present in apoE3 mice and was present to a lesser extent in apoE4 mice. There was a difference in acoustic startle response between apoE3 and apoE4 mice and between Apoe-/- and apoE3 or apoE4 mice [25]. Thus, the differential effects of apoE isoforms on measures of anxiety are not limited to avoidable anxiety-provoking stimuli. There were no differences in hearing threshold or fear-potentiated startle in the 6-month-old male groups.
###end p 23
###begin title 24
7. DEXAMETHASONE SUPPRESSION AND APOE4
###end title 24
###begin p 25
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 452 456 452 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 456 459 456 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 750 752 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 819 821 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 198 213 <span type="species:ncbi:10090">transgenic mice</span>
###xml 220 224 <span type="species:ncbi:10090">Mice</span>
###xml 471 475 <span type="species:ncbi:10090">mice</span>
###xml 528 532 <span type="species:ncbi:10090">mice</span>
###xml 586 590 <span type="species:ncbi:10090">mice</span>
Impaired suppression of cortisol levels after administration of dexamethasone is reported in AD [26]. Therefore, we examined whether dexamethasone could suppress plasma corticosterone in adult apoE transgenic mice [25]. Mice were injected with dexamethasone (0.1 mg/kg) or saline between 9:00 a.m. and 10:00 a.m., and trunk blood was collected 6 hours later [27]. Compared to saline, dexamethasone suppressed plasma corticosterone levels in wild-type, Apoe-/-, and apoE3 mice but dexamethasone suppression was impaired in apoE4 mice. The impaired dexamethasone suppression in the apoE4 mice might relate to other perturbations of cortisol responsivity observed in AD, including reduced cortisol-mediated regulation of hippocampal glucose metabolism [28] and dexamethasone sensitivity of peripheral blood nuclear cells [29].
###end p 25
###begin title 26
8. THE AMYGDALA AND APOE4
###end title 26
###begin p 27
###xml 239 242 239 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 362 363 362 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 440 443 440 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 552 554 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 624 631 624 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 697 704 691 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 856 863 844 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
###xml 269 273 <span type="species:ncbi:10090">mice</span>
###xml 444 448 <span type="species:ncbi:10090">mice</span>
###xml 536 541 <span type="species:ncbi:9606">human</span>
The differential effects of apoE on measures of anxiety were associated with neuropathological alterations in the central nucleus of the amygdala, which plays an important role in the regulation of anxiety. Compared to wild-type mice, Apoe-/- and apoE4, but not apoE3, mice had lower levels of microtubule-associated protein (MAP) 2-positive neuronal dendrites (P < .05). These changes were age-dependent. Three-month-old wild-type and Apoe-/- mice had similar levels of MAP 2-positive neuronal dendrites. Interestingly, in nondemented human subjects [30] and in AD subjects [31], amygdala atrophy increased with increasing epsilon4 allele dose. However, other studies did not find effects of the epsilon4 allele on amygdala atrophy. This might relate to differences in the mean age of the subjects in the different studies and a decrease in the effect of epsilon4 with advanced age.
###end p 27
###begin title 28
9. DIFFERENTIAL EFFECTS OF APOE ISOFORMS ON MEASURES OF ANXIETY IN PRAD PATIENTS
###end title 28
###begin p 29
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 364 371 360 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 373 380 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 399 406 381 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 408 415 384 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 434 441 402 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 443 450 405 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 612 619 566 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 621 628 569 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 685 692 627 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 694 701 630 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 713 714 643 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 767 774 697 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 776 783 700 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 832 839 750 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 841 848 753 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 1057 1064 963 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 1066 1073 966 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 1123 1130 1017 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 1132 1139 1020 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 1142 1143 1024 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1155 1162 1037 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 1164 1171 1040 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 1174 1175 1044 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 20 25 <span type="species:ncbi:10090">mouse</span>
###xml 120 128 <span type="species:ncbi:9606">patients</span>
Consistent with the mouse studies, apoE also has isoform-dependent effects on measures of anxiety in probable AD (PRAD) patients [25]. Diagnosis of probable AD was made in each case according to NINDS-ADRDA criteria [32]. Cornell depression scale and neuropsychiatric inventory (NPI) were recorded for all subjects (mean age +/- SEM; all subjects: 73 +/- 1 years; epsilon3/epsilon3: 75 +/- 3 years; epsilon3/epsilon4: 73 +/- 2 years; epsilon4/epsilon4: 71 +/- 2 years). Subjects were nonsmokers in good general health and free of past or present major psychiatric or neurological disorders (other than AD). Male epsilon4/epsilon4 subjects had higher anxiety scores than gender-matched epsilon3/epsilon3 subjects (P < .05). In males, but not in females, subjects with epsilon4/epsilon4 had also higher anxiety scores than those with epsilon3/epsilon4, suggesting that apoE3 can antagonize the effects of apoE4 on measures of anxiety in males but not in females. The anxiety scores did not correlate with the mini-mental state exam (MMSE) scores. Compared to epsilon3/epsilon3 male subjects, sleep disturbances were lower in epsilon4/epsilon4 (P < .01) and epsilon3/epsilon4 (P < .05) male subjects. Thus, sleep disturbances did not correlate or contribute to anxiety scores. ApoE did not have isoform-dependent effects on apathy or depression scores.
###end p 29
###begin title 30
10. CONCLUSIONS
###end title 30
###begin p 31
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 70 73 70 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 155 162 155 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 215 217 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 218 220 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 237 239 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 240 242 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 90 95 <span type="species:ncbi:9606">human</span>
###xml 338 346 <span type="species:ncbi:9606">patients</span>
ApoE isoforms have differential effects on measures of anxiety in Apoe-/- mice expressing human apoE3 or apoE4 at similar levels and in PRAD subjects. The epsilon4 allele is also associated with depression in some [33-35] but not other [36-40] studies. As noncognitive behavioral changes are the major cause of institutionalization of AD patients and a major concern for their caregivers, more research aiming at increasing our understanding of mechanisms underlying these behavioral changes is needed to advance treatment strategies to reduce these changes.
###end p 31
###begin title 32
ACKNOWLEDGMENTS
###end title 32
###begin p 33
###xml 193 194 193 194 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 249 250 249 250 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 308 309 308 309 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
This work was supported by Ellison Medical Foundation (EMF) AG-NS-0201, NIH Grant no. R01 AG20904, PHS Grant no. 5 M01 RR000334, and Alzheimer's Disease Center, NIA Grant no. P30 AG08017. The H3 ligands thioperamide, immepip, and clobenpropit, the H1 ligand mepyramine maleate (pyrilamine maleate), and the H2 ligand zolantidine we used were gifts from Dr. H. Timmerman and Dr. R. Leurs (Department of Pharmacochemistry, Free University of Amsterdam, The Netherlands).
###end p 33
###begin article-title 34
The impact of dementia on the family
###end article-title 34
###begin article-title 35
Predictors of behavioral disturbance in Alzheimer's disease
###end article-title 35
###begin article-title 36
Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias
###end article-title 36
###begin article-title 37
Factor associated with duration of survival in Alzheimer's disease
###end article-title 37
###begin article-title 38
Special care unit research: ethical issues
###end article-title 38
###begin article-title 39
The prognosis of depression in old age
###end article-title 39
###begin article-title 40
###xml 47 55 <span type="species:ncbi:9606">patients</span>
Frequency and characteristics of anxiety among patients with Alzheimer's disease and related dementias
###end article-title 40
###begin article-title 41
Assessment and treatment of neuropsychiatric symptoms in Alzheimer's disease
###end article-title 41
###begin article-title 42
Behavioural disorders in Alzheimer's disease. Data from a populational study
###end article-title 42
###begin article-title 43
###xml 61 69 <span type="species:ncbi:9606">patients</span>
Anxiety and nighttime behavioral disturbances. Awakenings in patients with Alzheimer's disease
###end article-title 43
###begin article-title 44
Apolipoprotein E: cholesterol transport protein with expanding role in cell biology
###end article-title 44
###begin article-title 45
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis
###end article-title 45
###begin article-title 46
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 50 53 50 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Hypothalamic-pituitary-adrenal dysfunction in Apoe-/- mice: possible role in behavioral and metabolic alterations
###end article-title 46
###begin article-title 47
###xml 88 91 <span type="species:ncbi:10116">rat</span>
Relationship between apolipoprotein E mRNA expression and tissue cholestorol content in rat adrenal gland
###end article-title 47
###begin article-title 48
###xml 87 90 <span type="species:ncbi:10116">rat</span>
Differential regulation of apolipoprotein-E messenger RNA in zona fasciculata cells of rat adrenal gland determined by in situ hybridization
###end article-title 48
###begin article-title 49
###xml 69 70 69 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 134 138 <span type="species:ncbi:10090">mice</span>
The behavioral and biochemical effects of thioperamide, a histamine H3-receptor antagonist, in a light/dark test measuring anxiety in mice
###end article-title 49
###begin article-title 50
###xml 9 10 9 10 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 85 88 85 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
Role of H3-receptor-mediated signaling in anxiety and cognition in wild-type and Apoe-/- mice
###end article-title 50
###begin article-title 51
###xml 106 110 <span type="species:ncbi:10090">mice</span>
Enrichment induces structural changes and recovery from nonspatial memory deficits in CA1 NMDAR1-knockout mice
###end article-title 51
###begin article-title 52
Androgens protect against apolipoprotein E4-induced cognitive deficits
###end article-title 52
###begin article-title 53
Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes
###end article-title 53
###begin article-title 54
###xml 114 118 <span type="species:ncbi:10090">mice</span>
Effects of drugs acting as histamine releasers or histamine receptor blockers on an experimental anxiety model in mice
###end article-title 54
###begin article-title 55
###xml 37 38 37 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 52 53 52 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
Effects of betahistine, a histamine H1 agonist and H3 antagonist, in a light/dark test in mice
###end article-title 55
###begin article-title 56
Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation: from obesity to memory deficits
###end article-title 56
###begin article-title 57
###xml 69 70 69 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 68 70 68 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1<italic>A</italic></sub>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice
###end article-title 57
###begin article-title 58
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 70 73 70 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 53 61 <span type="species:ncbi:9606">patients</span>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
apoE isoforms and measures of anxiety in probable AD patients and Apoe-/- mice
###end article-title 58
###begin article-title 59
Dexamethasone suppression test and serum prolactin in dementia disorders
###end article-title 59
###begin article-title 60
###xml 26 30 <span type="species:ncbi:10090">mice</span>
HPA axis dysregulation in mice overexpressing corticotropin releasing hormone
###end article-title 60
###begin article-title 61
Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease
###end article-title 61
###begin article-title 62
###xml 66 74 <span type="species:ncbi:9606">patients</span>
###xml 104 112 <span type="species:ncbi:9606">patients</span>
Differences in dexamethasone-sensitivity between lymphocytes from patients with Alzheimer's disease and patients with multi-infarct dementia
###end article-title 62
###begin article-title 63
Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes
###end article-title 63
###begin article-title 64
###xml 76 83 76 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon4 allele
###end article-title 64
###begin article-title 65
###xml 128 133 <span type="species:ncbi:9606">Human</span>
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Serives Task Force on Alzheimer's disease
###end article-title 65
###begin article-title 66
###xml 94 97 <span type="species:ncbi:9606">men</span>
Homocysteine, Alzheimer genes and proteins, and measures of cognition and depression in older men
###end article-title 66
###begin article-title 67
Depression, APOE genotype and subjective memory impairment: a cross-sectional study in an African-Caribbean population
###end article-title 67
###begin article-title 68
A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease
###end article-title 68
###begin article-title 69
A longitudinal study of apolipoprotein-E genotype and depressive symptoms in community-dwelling older adults
###end article-title 69
###begin article-title 70
Apolipoprotein-E (APO-E) genotype and symptoms of psychosis in Alzheimer's disease
###end article-title 70
###begin article-title 71
Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele
###end article-title 71
###begin article-title 72
Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's disease
###end article-title 72
###begin article-title 73
Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease
###end article-title 73
###begin p 74
###xml 24 28 <span type="species:ncbi:10090">mice</span>
Elevated plus maze: the mice are tested for 10 minutes; while they are curious to explore the open areas, they are anxious to do so.
###end p 74
###begin p 75
###xml 23 27 <span type="species:ncbi:10090">mice</span>
Passive avoidance: the mice are trained to avoid the preferred dark compartment by paring it with an aversive stimulus.
###end p 75
###begin p 76
###xml 22 26 <span type="species:ncbi:10090">mice</span>
Acoustic startle: the mice are placed on a sensing platform and their response to acoustic stimuli is recorded.
###end p 76
###begin p 77
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Elevated plus-maze performance of 6-8-month-old NSE-apoE mice.
###end p 77
###begin p 78
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 101 102 101 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
1There was a significance of genotype on ratio time in open arms/time in open + time in closed arms (P = .0094).
###end p 78
###begin p 79
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 31 34 31 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
*P < .05, wild-type versus Apoe-/-, apoE4, or apoE3/E4.
###end p 79
###begin p 80
###xml 2 3 2 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 21 24 21 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 43 44 43 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
**P < .05 versus Apoe-/- and apoE3/E4, and P < .01 versus apoE4.
###end p 80
###begin p 81
###xml 61 65 <span type="species:ncbi:10090">mice</span>
Elevated plus-maze performance in 6-month-old GFAP-apoE male mice.
###end p 81
###begin p 82
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apoe</italic>
###xml 20 23 20 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 33 34 33 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 24 28 <span type="species:ncbi:10090">mice</span>
*P < .05 versus Apoe-/- mice and P < .01 versus apoE4 (129) and apoE4 (130).
###end p 82

